Pathfinder Therapeutics, the Nashville-based VU spinoff that focuses on open and minimally invasive surgery using image-guided technologies, announced Sloan-Kettering and other universities are participating in clinical trials.
The release is here. Related
stories here.
No comments:
Post a Comment